AAP
AGN

Ardsley Advisory Partners’s Allergan plc AGN Stock Holding History

Ardsley Advisory Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-60,000
Closed -$13.9M – 216
2016
Q2 		$13.9M Buy
+60,000
New +$13.8M 2.41% 9

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Ardsley Advisory Partners's AGN Position: Q3 2017 in Review

Ardsley Advisory Partners sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 2,000 shares — an estimated $486K sold.

Ardsley Advisory Partners first reported a position in AGN in Q2 2013 and held it in 14 quarters. The position peaked at $1.21M in Q2 2015. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Ardsley Advisory Partners reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Ardsley Advisory Partners sold 2,000 Allergan plc shares in Q3 2017, an estimated $486K.
  • Ardsley Advisory Partners first reported a position in Allergan plc in Q2 2013 and held it in 14 quarters.
  • Ardsley Advisory Partners's Allergan plc position peaked at $1.21M in Q2 2015.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Ardsley Advisory Partners's 13F filing for Q3 2017, filed 14 Nov 2017.